InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immu... | 2023 | PLoS One | Laotee S. et al. | DOI: 10.1371/journal.pone.0288486 |
| Quil-A® adjuvant | CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immu... | 2023 | PLoS One | Laotee S. et al. | DOI: 10.1371/journal.pone.0288486 |
| Poly(I:C) (HMW) VacciGrade™ | CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immu... | 2023 | PLoS One | Laotee S. et al. | DOI: 10.1371/journal.pone.0288486 |
| pFUSE-hIgG1-Fc | CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immu... | 2023 | PLoS One | Laotee S. et al. | DOI: 10.1371/journal.pone.0288486 |
| Poly(dA:dT) | Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflamma... | 2023 | Front Immunol. | Chew Z.H. et al. | DOI: 10.3389/fimmu.2023.1211730 |
| PMA - Phorbol myristate acetate | Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflamma... | 2023 | Front Immunol. | Chew Z.H. et al. | DOI: 10.3389/fimmu.2023.1211730 |
| LPS-EK (LPS from E. coli K12) | Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflamma... | 2023 | Front Immunol. | Chew Z.H. et al. | DOI: 10.3389/fimmu.2023.1211730 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer... | 2022 | Biomed Pharmacother. | Lin H.Y. et al. | DOI: 10.1016/j.biopha.2021.112431 |
| Normocin® - Antimicrobial Reagent | CDK2 inhibition enhances antitumor immunity by increasing IFN response to end... | 2022 | Cancer Immunol Res. | Chen Y. et al. | DOI: 10.1158/2326-6066.CIR-21-0806 |
| Puromycin | CDK2 inhibition enhances antitumor immunity by increasing IFN response to end... | 2022 | Cancer Immunol Res. | Chen Y. et al. | DOI: 10.1158/2326-6066.CIR-21-0806 |
| Plasmocure™ - Mycoplasma Elimination Reagent | CDK2 inhibition enhances antitumor immunity by increasing IFN response to end... | 2022 | Cancer Immunol Res. | Chen Y. et al. | DOI: 10.1158/2326-6066.CIR-21-0806 |
| Plasmocure™ - Mycoplasma Elimination Reagent | Pantothenate and L-Carnitine Supplementation Improves Pathological Alteration... | 2022 | Genes (Basel) | Munuera-Cabeza M. et al. | DOI: 10.3390/genes13122300 |
| Normocure™ - Antimicrobial Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
| Fungin™ - Antifungal Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
| Normocin® - Antimicrobial Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
| Plasmocin® - Mycoplasma Elimination Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
| Plasmocure™ - Mycoplasma Elimination Reagent | A Beginner's Guide to Cell Culture: Practical Advice for Preventing Needless ... | 2023 | Cells | Weiskirchen S. et al. | DOI: 10.3390/cells12050682 |
| Normocin® - Antimicrobial Reagent | HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Che... | 2023 | Cancer Immunol Res. | Li L. et al. | DOI: 10.1158/2326-6066.CIR-22-0317 |
| Plasmocure™ - Mycoplasma Elimination Reagent | HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Che... | 2023 | Cancer Immunol Res. | Li L. et al. | DOI: 10.1158/2326-6066.CIR-22-0317 |
| Puromycin | HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Che... | 2023 | Cancer Immunol Res. | Li L. et al. | DOI: 10.1158/2326-6066.CIR-22-0317 |